Next-generation sequencing for the diagnosis of primary muscle disorder: the experience of the Dino Ferrari Center in Milan.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingMuscle MRI findings in Italian patients with myofibrillar and distal myopathies: an exploratory analysis from ITA-MeD.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingNeed for tube feeding in SMA type I patients treated with disease modifying therapies: prognostic factors
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingBeyond exome-targeted sequencing approaches to increase the diagnostic rate of unsolved neuromuscular disease patients
/0 Commenti/in GRUPPO 3, musumeci, servidei, Uncategorized/da expomeetingNovel TMEM43 mutations lead to extreme variability of clinical phenotype
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingRapid regression of bulbar symptoms in myasthenia gravis refractory clinical relapse after eculizumab infusion as rescue therapy
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingCardiac comorbidities in McArdle disease: case report and systematic review
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingLong lasting effectiveness of Efgartigimod in anti-acetylcholine receptor antibodies positive Myasthenia Gravis.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingPrompt diagnosis and treatment of TK2 mitochondrial myopathy: a case report.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingSEGRETERIA NAZIONALE AIM
Seguici sulle nostre pagine social
SEGRETERIA ORGANIZZATIVA FIRST CLASS
First Class S.r.l. Meetings and Conferences